Year: 2026
Type: article
Abstract: Adeno-Associated Viruses (AAVs) are powerful platforms for delivering therapeutic transgenes via recombinant AAV (rAAV) vectors. However, a limited understanding of the regulation of AAV gene expression has narrowed the ability to efficiently express therapeutic transgenes from rAAV vectors. Since rAAVs retain only the wtAAV inverted terminal repeats (ITR), we hypothesized that regulatory elements outside the ITR that govern wild-type AAV (wtAAV) gene expression can be used to modify rAAV genomes to enhance vector performance. Through in silico analysis, biochemical pulldowns, and high-throughput sequencing, we have identified that the host architectural protein CCCTC-binding Factor (CTCF) associates with the wtAAV type 2 (wtAAV2) genome but is absent from rAAV vectors. Global knockdown and site-specific deletion revealed that the CTCF binding element (CBE) on the wtAAV2 genome, located upstream of the viral P5 promoter, regulates expression of the viral Rep68/78 genes. We have re-engineered new rAAV vectors expressing a GFP reporter transgene to contain the wtAAV2-CBE upstream of the vector promoter. Our results show that CTCF binding dramatically increased rAAV transduction efficiency and GFP expression by up to four-fold across multiple cell types. This enhancement was independent of the AAV capsid serotype used for packaging rAAV vectors. CUT&RUN analysis revealed that this CBE was necessary and sufficient to regulate the chromatin landscape of wtAAV2 and rAAV2. Finally, we observed that CTCF-mediated chromatin remodeling of rAAV2 led to increased production of nascent RNA transcripts from the vector genome. Based on our findings, we propose that CTCF supports wtAAV2/rAAV gene expression by shaping the local chromatin landscape.
Source: PLoS Pathogens
Authors: Clairine I.S. Larsen, Rhiannon R. Abrahams, Rea Guertler, Elliott M. Wilion, Eda Erata, Zachary H. Sykes, Lorelei I. Stoica, Gopishankar Thirumoorthy, Divya Sinha, Richa Rai, Joydeb Majumder, Elizabeth K. Hofer, Eleanor Hart, Eishika Dissanayake, James E. Gern, David M. Gamm, William L. Murphy, Matthew S. Fuller, Kinjal Majumder
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,043
Funders: National Science Foundation, Research to Prevent Blindness, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, University of Wisconsin-Madison, University of Wisconsin Carbone Cancer Center, Waisman Center, Ultragenyx Pharmaceutical, Retina Research Foundation, National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, National Center for Advancing Translational Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Science Foundation Graduate Research Fellowship Program
Awards: G1236303967, G2780014678, How does a viral pathogen manipulate DNA Damage Responses to promote infection?, G3892861298, G4004214011, G4305155978, G4307208066, G4440838025, G4921962326, G5813506420, Graduate Research Fellowship Program (GRFP), How does a viral pathogen manipulate DNA Damage Responses to promote infection?, Harnessing human brain and liver microphysiological systems for testing therapeutics for metastatic melanoma, G7259970065, G7510161112, G9000232554, UW Comprehensive Cancer Center Support, Waisman Center Intellectual and Developmental Disabilities Research Center, Defining how cellular DNA replication and repair machinery are hijacked by viral pathogens, G9001368358, G9001368749
OpenAlex ID: W7163553667
